LIMNW vs SPG
Liminatus Pharma, Inc. Warrants (LIMNW) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.
SPG (SPG) common stock.
LIMNW does not have a complete income-statement cache yet.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
LIMNW currently screens at market cap $0. SPG currently screens at market cap $0.
Not investment advice. Open the LIMNW and SPG stock pages for the full models.
Not investment advice.